Intas is one of the leading global pharmaceutical formulation development, manufacturing, and marketing companies. The company also has a presence in the cardiovascular system, diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management as well as other therapeutic segments. As on date, Intas commercialized 11 biologic products and continues its R&D efforts in chronic disease areas such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma-derived product based therapies.